SEP Acquisition Corp (SEPA) Financial Statements (2025 and earlier)
Company Profile
Business Address |
3737 BUFFALO SPEEDWAY HOUSTON, TX 77098 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 17 | 1,344 | 842 | |||
Cash and cash equivalent | 17 | 1,344 | 842 | |||
Other undisclosed cash, cash equivalents, and short-term investments | ||||||
Prepaid expense | 21 | 165 | 465 | |||
Other undisclosed current assets | ||||||
Total current assets: | 38 | 1,509 | 1,307 | |||
Noncurrent Assets | ||||||
Asset, held-in-trust | 13,656 | 182,249 | ||||
Other undisclosed noncurrent assets | 22,469 | |||||
Total noncurrent assets: | 13,656 | 22,469 | 182,249 | |||
TOTAL ASSETS: | 13,693 | 23,978 | 183,556 | |||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities, including: | 1,205 | 63 | 117 | |||
Taxes payable | ✕ | ✕ | ✕ | 167 | ||
Accrued liabilities | 108 | 509 | ||||
Other undisclosed accounts payable and accrued liabilities | 1,097 | (446) | (50) | |||
Debt | 758 | |||||
Derivative instruments and hedges, liabilities | 79 | |||||
Other liabilities | 190 | 960 | ||||
Other undisclosed current liabilities | 208 | 9,708 | 167 | |||
Total current liabilities: | 2,440 | 10,731 | 284 | |||
Noncurrent Liabilities | ||||||
Liabilities, other than long-term debt | 1,277 | 852 | 7,495 | |||
Derivative instruments and hedges, liabilities | 1,277 | 852 | 7,495 | |||
Other undisclosed noncurrent liabilities | 6,315 | 6,315 | ||||
Total noncurrent liabilities: | 1,277 | 7,166 | 13,809 | |||
Total liabilities: | 3,717 | 17,897 | 14,094 | |||
Temporary equity, including noncontrolling interest | 13,656 | 13,333 | 182,249 | |||
Equity | ||||||
Equity, attributable to parent, including: | (3,680) | (7,251) | (12,786) | |||
Accumulated deficit | (3,680) | (7,252) | (12,787) | |||
Other undisclosed equity, attributable to parent | 0 | 0 | 0 | |||
Total equity: | (3,680) | (7,251) | (12,786) | |||
TOTAL LIABILITIES AND EQUITY: | 13,693 | 23,978 | 183,556 |
Income Statement (P&L) ($ in thousands)
3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
---|---|---|---|---|---|
Revenues | 307 | 2,753 | |||
Realized investment gains | 307 | 2,753 | |||
Gross profit: | 307 | 2,753 | |||
Operating expenses | (2,878) | (1,174) | |||
Other undisclosed operating loss | (307) | (2,753) | |||
Operating loss: | (2,878) | (1,174) | |||
Nonoperating income (expense) | 439 | 9,393 | |||
Investment income, nonoperating | 48 | 6,643 | |||
Interest and debt expense | |||||
Other undisclosed income from continuing operations before equity method investments, income taxes | |||||
Income (loss) from continuing operations before equity method investments, income taxes: | (2,439) | 8,219 | |||
Other undisclosed loss from continuing operations before income taxes | (10,397) | ||||
Loss from continuing operations before income taxes: | (2,439) | (2,178) | |||
Income tax expense (benefit) | 84 | (507) | |||
Other undisclosed income from continuing operations | |||||
Net loss: | (2,355) | (2,684) | |||
Other undisclosed net income attributable to parent | 10,397 | ||||
Net income (loss) attributable to parent: | (2,355) | 7,713 | |||
Preferred stock dividends and other adjustments | 323 | (161,958) | |||
Other undisclosed net income available to common stockholders, basic | 159,780 | ||||
Net income (loss) available to common stockholders, diluted: | (2,032) | 5,535 |
Comprehensive Income ($ in thousands)
3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
---|---|---|---|---|---|
Net loss: | (2,355) | (2,684) | |||
Comprehensive loss, net of tax, attributable to parent: | (2,355) | (2,684) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.